Prevalence of hepatitis B virus infections among blood donors in Federal Capital Territory, Abuja, Nigeria by Ezeonu, C.M. et al.




Ezeonu et al. Afr. J. Clin. Exper. Microbiol. 2019; 20 (3): 182-194    https://www.afrjcem.org 
 
African Journal of Clinical and Experimental Microbiology ISSN 1595-689X  July 2019 Vol.20 No.3 
AJCEM/1938: https://www.ajol.info/index.php/ajcem        
Copyright AJCEM 2019 https://dx.doi.org/10.4314/ajcem.v20i3.3            
 
Original Article                  Open Access 
 
Prevalence of hepatitis B virus infections among blood 
donors in Federal Capital Territory, Abuja, Nigeria 
 
Ezeonu, C. M., Garba, S. A., Adabara, N. U., and Kuta, F. A. 
 
Department of Microbiology, School of Life Sciences, Federal University of Technology, Minna, Nigeria 




Background: Transfusion of hepatitis B virus (HBV) infected blood represents a major but avoidable 
means of HBV transmission, which unfortunately still account for millions of global HBV infections 
annually.  
Method: This study determined the prevalence of HBV infection among 550 blood donors aged 18 to 
60 years from selected hospitals and blood transfusion centres within the Federal Capital Territory, 
Nigeria, using hepatitis B surface antigen (HBsAg) rapid diagnostic test (RDT) kit and Enzyme linked 
Immuno-sorbent Assay (ELISA). Representative positive and negative samples for RDT and ELISA 
were tested by both conventional and real-time polymerase chain reaction (PCR) assay   
Results: Forty nine (8.9%) and 14 (2.8%) out of the 550 blood donors tested positive for HBsAg with 
the RDT and ELISA respectively. Replacement donors had higher prevalence rate of the HBV infection 
than voluntary donors. The highest prevalence of HBV infection was recorded among the 30–39 year 
age group. The difference in the rate of infection between the males and the females was not 
statistically significant (p>0.05). A perfect agreement between RDT and PCR and fair agreement 
between ELISA and PCR were observed. 
Conclusion: This study report a high prevalence of hepatitis B virus infections among blood donors in 
Abuja, Nigeria which underscores the need for proper screening of blood for transfusion to completely 
eliminate the incidence of transfusion transmitted HBV infections. 
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Contexte: La transfusion de sang infecté par le virus de l'hépatite B (VHB) représente un moyen 
important mais évitable de transmission du VHB, qui représente malheureusement toujours des 
millions d'infections mondiales au VHB chaque année. 
Méthode: Cette étude a déterminé la prévalence de l’infection à VHB chez 550 donneurs de sang âgés 
de 18 à 60 ans de certains hôpitaux et centres de transfusion sanguine situés dans le Territoire de la 
capitale fédérale, au Nigéria, à l’aide du kit de test de diagnostic rapide (TDR) de l’antigène de 
l’hépatite B (HBsAg) et Essai immuno-sorbant lié à une enzyme (ELISA). Des échantillons positifs et 
négatifs représentatifs pour les TDR et ELISA ont été testés à la fois par le test de réaction en chaîne 
par polymérase (PCR) classique et en temps réel                   
Résultats: Quarante-neuf (8,9%) et 14 (2,8%) des 550 donneurs de sang ont été testés positifs pour 
HBsAg avec le TDR et le test ELISA, respectivement. Le taux de prévalence de l’infection à VHB était 
plus élevé chez les donneurs de remplacement que chez les donneurs volontaires. La prévalence la 
plus élevée d'infection par le VHB a été enregistrée dans le groupe d'âge des 30 à 39 ans. La 
différence de taux d'infection entre les hommes et les femmes n'était pas statistiquement significative 
(p> 0,05). Un accord parfait entre TDR et PCR et un accord juste entre ELISA et PCR ont         
Conclusion: Cette étude fait état d’une prévalence élevée d’infections par le virus de l’hépatite B chez 
les donneurs de sang à Abuja, au Nigéria, ce qui souligne la nécessité d’un dépistage approprié du 
sang par transfusion afin d’éliminer 
 




 About 2 billion people worldwide 
have been infected with Hepatitis B Virus 
(HBV). An estimated 360 million people 
remain chronically infected with 2 million 
deaths   annually (1). Hepatitis B viral 
infections are caused by the HBV; an 
envelope virus containing a partially 
double stranded circular DNA genome and 
classified within the family hepadnaviridae 
(2). HBV infects the liver, thereby 
impairing liver functions as the virus 
replicates within the hepatocytes during 
acute and chronic phases of HBV 
infections (3). According to the Centre for 
Disease Control and Prevention (CDC), 
HBV is present in the blood, blood 
products and body fluids such as vaginal 
secretions, semen and in low 
concentrations in the saliva of the carriers 
(4).      
 Among the various routes of 
transmission of HBV infection, blood 
transfusion transmission represents a 
deliberate process of transmission that 
can be avoided even with the slightest 
vigilance (5). In 2001, WHO estimated 
that transfusion of unsafe blood alone 
accounted for 8-16 million hepatitis B 
virus infections annually. Although, the 
incidence of transfusion transmitted 
hepatitis B has been gradually controlled 
within the intervening period, the 
available records show that HBV remains 
yet the viral infection with the greatest 
risk of transmission through blood 
transfusion especially in developing 
countries. An obviously high variability in 
the prevalence of HBV is seen across the 
countries, with higher incidence and 
prevalence observed in developing nations 
such as 1.6%–7.7% in Brazil, 19.6% in 
Egypt and 2-10% across India (6). In 
Nigeria, the pooled prevalence of HBV is 
reported to be about 13.6% (7).  
 Even though there are routine tests 
for demonstrating the presence or 
otherwise of this infection, the greatest 
risk are blood donations made in the 
infectious window period, which is the 
time between development of infectious 
viraemia and/or reactivity to routine 
serological or nucleic acid technology 
(NAT) based screening tests (8). The 
safety of blood can be guaranteed by 
application of assay technologies with high 
specificity and sensitivity so as to be able 
to identify all true positive blood units and 
true negative blood units (9). Screening of 
blood donors is a critical issue as the 
outcome of the test if flawed for whatever 
reason can result in serious consequences 




for either the blood service or the blood 
donor. False positive result can lead to a 
larger number of blood donors being 
deferred, while a false negative testing 
may jeopardize blood safety (10).  
 In Nigeria, the prevalence of HBV 
infection has been speculated to vary with 
regard to the screening method used with 
prevalence rates varying from 12.3% by 
enzyme linked immunosorbent assay, 
17.5% by immuno-chromatography and 
13.6% by HBV DNA polymerase chain 
reaction (11). It is therefore necessary to 
monitor the safety of blood supply and the 
effectiveness of the presently employed 
screening procedures since pregnant 
women and children are the major 
recipient. The aim of this study was to 
determine the prevalence of Hepatitis B 
Virus among blood donors and to compare 
the sensitivity of HBV detection methods 
employed in the study area. 
 
Materials and methods: 
  
Study area 
 The study areas are blood bank 
units of Asokoro, Maitama, Wuse District 
Hospital; National Blood Transfusion 
Services; Federal Medical Centre Jabi, 
Karishi and Nyanya General Hospital, all in 
the Federal Capital Territory (FCT), Abuja, 
Nigeria.  
 
Study design  
 The study is a descriptive cross 
sectional survey of blood donors which 
include voluntary, family/replacement 
donors, and commercial/paid donors 
which are not recorded. 
 
Ethical clearance 
 The study was approved by the 
Health Research Ethics Committee of the 
Federal Capital Territory, Abuja and other 
ethics body of the chosen blood bank 
centres where applicable. 
 
Study population  
 There were a total of 550 subjects 
comprising 521 (94.7%) males and 29 
(5.3%) females who came to the blood 
bank units of the hospitals to donate 
blood. Sixty-three (11.5%) out of the 550 
were voluntary donors while 487 (88.5%) 
were family replacement donors. No 
commercial/paid donors participated in 
the study. Participation in the study was 
based on informed consent while 
demographic data about subjects were 




 All the subjects satisfied the 
qualifying criteria of age between 18 - 60 
years, body weight of above 50 kg 
depending on the body mass index (BMI), 
haemoglobin requirement of more than 
12.5 gm/dl and absence of significant 
medical or surgical history. All donors 




 Donors who did not meet the 
conditions spelt out in the inclusion 
criteria as well as those who did not 
consent to participate in the study, 
lactating mothers, pregnant or 
menstruating women, donors who did not 
meet the haemoglobin requirements, 
those who have donated more than the 
prescribed 3 times in the last 12 months 
and other requirements were excluded 
from participation in the study. 
 
Samples collection and analysis  
 Five milli-liters of whole blood were 
obtained via venipuncture from the donors 
using 5 ml syringe (12). To ensure 
confidentiality of the donors, numbers 
were used. Two milli-liters of these were 
placed in ethylene diamine tetra acetic 
acid (EDTA) bottle for haematological 
screening of HBsAg. The remaining 3mls 
were dispensed into a red top vaccutainer 
tube, then allowed to clot naturally at 
room temperature, centrifuged at 
3000rpm for 5minutes to obtain the 
serum and was pipetted out of the 
vaccutainer tube which was used for  
immunological analysis of HBsAg. 
 
Rapid Diagnostic Test for HBsAg detection  
 Twenty five micro liters of serum 




was added to the specimen well of the 
RDTs with the aid of pipette. The serum 
reacted with the particle coated with 
monoclonal anti-HBsAg. The mixture then 
migrates upward along the membrane by 
capillary action and reacts with polyclonal 
anti-HBsAg, which are pre-coated on the 
test region. After 15 minutes, invisibility 
of the control line indicated invalid result. 
The presence of two distinct lines in both 
the control and test regions indicated a 
positive result while one red line in the 
control region is a negative result. Strips 
used were from ACON® on the 
instructions of the manufacturers.  
 
Enzyme Linked Immuno Sorbent Assay 
(ELISA) for HBV antibody detection 
 ELISA assay (ADALTIS, S. r, I 
Milano, Italy) was used to reconfirm blood 
samples that yielded negative results from 
RDTs screening tests to quantify the 
absence of anti-bodies to HBsAg. The 
procedure was carried out according to 
the manufacturer’s instructions. First, 20 
μL of assay diluent was added into each 
well except the blank, and 100 μL of 
positive control, negative control and 
specimen were added into their respective 
wells except the blank. The plates were 
covered and incubated for 60 minutes at 
37ºC. After incubation, plate cover were 
discarded and 50 μL conjugate was added 
into each well (except the blank) and mix 
by tapping the plate gently. Each plate 
was covered and incubated for 30 minutes 
at 37ºC. Following incubation, plate cover 
was discarded and each well was soaked 
for 30-60 seconds before washing for 5 
times with diluted washing buffer. After 
the final cycle of washing, the plate was 
turned down on a blotting paper and 
gently tapped to remove any remainders. 
 To each well of the plate, including 
the blank, 50 μL of substrate solution ‘‘A” 
and 50 μL of substrate solution ‘‘B”, were 
added. The plate was incubated at 37ºC 
for 30 minutes without exposure to light. 
The enzymatic reactions that occurred 
between the substrate solutions and the 
conjugate produced blue colour in positive 
control and HBsAg positive sample wells. 
50 μL of stop solution was added into each 
well and mixed gently. Intensive yellow 
colour developed in positive control and 
HBsAg positive sample wells. Plate reader 
was calibrated with the blank well and the 
absorbance read at 450 nm. The cut of 
value was calculated and result evaluated 
by reading the absorbance within 10 
minutes after stopping the reaction.  
 
Polymerase chain reaction (PCR) assays 
for HBV DNA  
 Three RDT positive HBsAg samples, 
and two positive and seven negative 
ELISA samples were subjected to both 
conventional PCR (BIONEER, USA) and 
real time PCR (DAAN Gene, 
Biotechnology, China) assays, at the DNA 
LABS Limited, Q5 Danja, off Katuru Road, 
Kaduna State, Nigeria, according to the 
manufacturer’s instructions. 
DNA extraction 
 DNA was extracted from 100 μL 
serum sample using DAAN Gene DNA kit 
(cat.♯ DA-451, China) as follows; 50 μl of 
Proteinase K was pipetted into the bottom 
of a 1.5 mL centrifuge tube. 200 μL of 
fluid sample was added to the tube, and 
200 μL of virus lysing solution was then 
added and mixed by pulse-vortexing for 
15 seconds. The resulting mixture was 
incubated at 72ºC for 10 min followed by 
a short spin down. 250 μL of ethanol (96-
100 %) was added to the sample, mixed 
by vortexing and briefly centrifuged to 
remove drops from the inside of the tube 
lid. The mixture was applied carefully to 
the spin column (in a 2mL collection tube) 
without wetting the rim. The cap was 
closed and column in the collection tube 
was centrifuged at 12,000 rpm for 1 min. 
 The Mini spin column was placed in 
a clean 2 mL collection tube, and the tube 
containing the filtrate discarded. 500 μL of 
inhibitor removal and 500 μL of desalting 
solution (twice) were added to spin 
column without wetting the rim and 
centrifuged at 12,000 rpm for 1 min at 
room temperature and the spin column 
was replaced in a clean 2 mL collection 
tube. Filtrate was discarded in each step. 
Finally, the spin column was placed at 
room temperature in a clean centrifuge 
tube, 50 μL elution buffers was added to 




the column and centrifuged at 14000 rpm 
for 3 minutes. The filtrate in this step 
resembles the isolated DNA. 
Conventional PCR assay 
 Conventional PCR was performed 
using Bioneer AccuPower PCR PreMix a 
ready-to-use PCR reagent, which consist 
of lyophilized mix of; thermostable 
enzyme, dNTPs, reaction buffer, stabilizer, 
tracking dye and PCR product purification. 
A water/primer mix was prepared in a 0.5 
mL Eppendorf tube on ice consisting of 2 
μL of each primer (forward and reverse) 
and 280 μL of ultra-pure water. One strip 
of 6 Bioneer Premix tubes was labeled 1 
to 6 including the positive and negative 
control and 16 μL of the water/primer mix 
was added to each of the 6 tubes with 2 
μL of sample. These were placed in thin 
walled tubes inserted in the programmed 
PCR thermal cycler (Biometra's T 
Gradient). 
 The amplification reaction started 
with 3 min at 95°C for 1 cycle, followed by 
30 seconds at 94°C, 45 seconds at 45°C, 
1 minute at 72°C for 35 cycles, followed 
by final extension at 72°C for 7 minutes, 
and then soaked for 1 minute at 20°C. 
The primer pair, HepBP1: 5'-TCA CCA TAT 
TCT TGG GAA CAA GA-3' and HepBS1-2: 
5'-CGA ACC ACT GAA CAA ATG GC-3', 
were used. The PCR products were 
electrophoresed on 3% agarose gels and 
DNA was visualized by ultraviolet trans-
illuminator. Bands were compared by size 
with the presence of 350 bp DNA ladder 
fragment indicating a positive result. 
Real Time PCR assay 
 Real Time PCR was performed 
using ABI Prism 7500 (Applied Biosystem, 
USA). All positive controls, negative 
controls and samples were tested in 
duplicates. 27 μL HBV-PCR and 3 μl Taq 
enzyme for each sample were properly 
mixed. A filter tip was used to add 20 μL 
supernatant of extracted DNA, HBV 
negative quality control product, HBV 
strong positive quality control product, 
HBV critical positive quality control 
product, and positive quantitative 
reference, into the HBV reaction tube. The 
tube was centrifuged at 8,000 rpm for 
several seconds and samples were 
transferred to PCR amplification detection 
region using the cyclic conditions, 
temperatures and channels as follows; In 
stage 1 with ABI Prism 7500 instrument 
setup, detection channels used are FAM, 
VIC and ROX at 93oC for 2 minutes of 1 
cycle. In stage 2 with Light cycler 4800 
setup, detection channels used are FAM 
and VIC at 93oC for 45 minutes and 55oC 
for 60 seconds of 10 cycles. In stage 3 
with DA7600 instrument setup, detection 
channels used are FAM and HEX at 93oC 
for 30 seconds and 55oC for 45 seconds, 
of 30 cycles 
 
Statistical analysis: 
 Data generated were analyzed 
using the Statistical Package for the Social 
Sciences (SPSS) version 20.0 and Chi-
square (X²) test was used to measure 
significant relationship between different 
sociodemographic characteristics among 




Prevalence of hepatitis B virus infections 
 Out of the 550 blood samples 
obtained from the blood donors, 49 
(8.9%) were positive for HBsAg with the 
RDTs while 14 (2.8%) were positive with 
ELISA. The age range of the donor is 18 to 
60 years, with the majority of the donors 
(335) aged between 30 and 39 years, 
which also has the highest prevalence of 
HBV infections (Table 1). Both males and 
female donors tested positive for HBV 
(Table 2), with higher rates observed 
among the male subjects, 47 (9.0%) with 
RDT and 14 (2.9%) with ELISA compared 
to female subjects, 2 (6.8%) with RDT 
and none (0%) with ELISA. From the 
result of the RDT, replacement donors had 
a significantly higher rate of infection than 
voluntary donors (p = 0.008) (Table 3). 
DNA analyses of 12 samples (3 positive 
with RDT, 2 positive with ELISA and 7 
negative with ELISA) were carried out by 
PCR (both real time and conventional 
PCR) as shown in Figures 1, 2 and 3. The 
samples were randomly selected upon 
screening them for HBsAg with RDT and 
confirmation with ELISA. 




Table 1: Age group distribution of donors with HBV infections 
 
Age group (years) 
 
Number Examined Number 
infected 
(RDT) (%) 
Number         
infected 
(ELISA) (%) 
< 20 1 0 (0.0) 
 
0 (0.0) 
20 – 29 83 8 (9.6) 1 (1.3) 
30 – 39 335 31 (9.3) 11 (3.6) 
≥ 40 131 10 (7.6) 2 (1.6) 
Total 550 49 14 
χ2 0.464 2.017 
p value 0.927 0.569 
 
 
Table 2: Gender distribution of hepatitis B virus infection among blood donors 
 












Male 521 47 (9) 0.003138 0.9553 473 14 (2.9) 0.5180 0.4717 
Female 29 2 (6.8) 17 0 
Total 550 49 (8.9) 490 14 (2.8) 
 
Table 3: Prevalence of hepatitis B virus infection among blood donor types 
 










Voluntary  63 0 (0.0) 63 2 (3.2) 
Family/Replacement  487 60 (13.6) 427 12 (2.7) 
Commercial  0 0 (0.0) 0 0 (0.0) 
χ2  6.959                          0.043 
p value  0.008**                      0.835 
 
 
 The identification codes for the 12 
samples are stated besides the Figures. 
Three (100%) positive samples from RDTs 
were positive with PCR. Also, 2 (22.2%) 
positive and 7 (77.8%) negative samples 
with ELISA were negative with real time 
PCR. In Figure 1, the curves in the graph 
represent positive samples with different 
viral load values of HBV DNA in the 
samples upon confirmation with real time 
PCR, while absence of values and curves 
in Figure 2 showed negative samples. In 
Figure 3, conventional PCR also confirmed 
the 2 positive and 1 negative ELISA 
samples as negative with marker at 350 
bp DNA ladder. Tables 4, 5 and 6 show 
the sensitivity, specificity and accuracy of 
RDTs, ELISA and real time PCR methods 
of HBV detection used in this study. 







Fig 1: Amplification of extracted DNA from 3 positive RDTs, 2 positive ELISA and 7 negative ELISA samples using rt 
PCR. The curves on the graphs with the values on the table signify positive HBV samples from positive control and 






Fig 2: Amplification of extracted DNA from 3 positive RDTs, 2 positive ELISA and 7 negative ELISA samples using 
real-time PCR. The absence of curves on the amplified graphs with absence of values on some of the columns 
signifies that the 2 positive and 7 negative samples from ELISA tested negative after using real- time PCR  
 
 






Fig 3: Agarose electrophoresis use to reconfirm 2 positive and 1 negative ELISA samples that were found to be 
negative using rt PCR  
 
Table 4: Detection rate of HBV by RDT and ELISA tests 
 
    ELISA Total (%) Kappa 










 Reactive 3 (100.0) 0 (0.0) 3 (100.0) 0.304* 
Non-reactive 2 (22.2) 7 (77.8) 9 (100.0)  
Total 5 (41.7) 7 (58.3) 12 (100.0)  
* = there’s agreement between the two test methods. The two test methods will agree on 304 out of 550 samples 
 
 
Table 5: Detection rate of HBV using ELISA and RT PCR 
 
  ELISA Total (%) Kappa 










Reactive 3 (100.0) 0 (0.0) 3 (100.0) 0.304 
Non-reactive 2 (22.2) 7 (77.8) 9 (100.0)  
Total 5 (41.7) 7 (58.3) 12 (100.0)  
* = there’s agreement between the two test methods. The two test methods will agree on 304 out of 550 samples 
 
 




Table 6: Detection rate of HBV using RDT and PCR 
 
  PCR Total (%) 
  
  









Reactive 3 (100.0) 0 (0.0) 3 (100.0) 1.000* 
Non-reactive 0 (0.0) 9 (100.0) 9 (100.0)  
Total 3 (25.0) 9 (75.0) 12 (100.0)  
 
HBV infections and sociodemographic 
characteristics of blood donors 
 The prevalence of HBV infection 
estimated by RDTs and ELISA methods in 
relation to marital status was higher with 
16.7% rate in divorced/separated donors 
(with RDTs), and 5.0% in singles (with 
ELISA) but this relationship is not 
statistically significant (p>0.05). In 
relation to occupational status, farmers 
had a higher prevalence of HBV infection 
with 17.0% but this was also not 
statistically significant (p>0.05). For 
educational status, the infection rate was 
higher in those with primary level 
education with 100% rate.  
 Analysis by risk factors in Table 7 
shows association of HBV infections with 
factors such as tattooing, cauterization, 
blood transfusion, scarification, lack of 
vaccination, unprotected sex, multiple sex 
partners, anal sex, intravenous drug use, 





 According to the WHO criteria, the 
prevalence rate of 8.9% for HBsAg among 
blood donors in the Federal capital 
Territory, Abuja, Nigeria reported in our 
study is high (13). This rate is higher than 
1.1% reported in Port-Harcourt (14), 
2.4% in Yola (15), 4.2% in Zaria (16) and 
5.9% in Ibadan (17). But our rate is lower 
than 20% reported in Benue State (18) 
and 17.5% in Abuja by Agbesor et al. 
(19). In Burkina Faso, a high prevalence 
rate of 17.3% was reported (20), 11.2% 
in Cameroon (21) but low rate of 2.48% 
was reported in Northern Karnataka, India 
(22). Although it is difficult to explain the 
differences in the rate reported in our 
study and those of others, the variations 
observed may be related to the 
differential knowledge about hepatitis risk 
factors, mode of transmission, and 
information or lack of it on how to make a 
diagnosis of hepatitis B virus infections in 
health centres.   
 The majority of donors (88.5%) 
tested in this study were family 
replacement donors rather than voluntary 
non-remunerated donors (11.5%). The 
number of voluntary blood donors has 
continued to decline over the years in 
Nigeria and the net result is that 
commercial and family replacement 
donors persist. Family replacement donors 
accounted for a significant number of HBV 
infection compared to voluntary non-
remunerated donors. This observation is 
consistent with the WHO suggestion (23) 
that the safest source of blood is 
voluntary non-remunerated donors. This 
is because replacement donors have long 
been regarded as higher risk based upon 
the assumption that friends or relatives 
are more likely to deny or ignore risk 
factors that invite further inquiry, 
removing the protection afforded by risk-
screening questionnaires in favor or 




coercion to donate. Furthermore, where 
there is urgent need to procure donors, 
family members may pay donors for their 
services thereby compounding transfusion 
risk.      
 The associated risky behaviours of 
the blood donors positively correlated with 
the rate of HBV infection among the blood 
donors. This was obvious in the case of 
people who admitted to having incomplete 
or no HBV immunization history. The 
prevalence rate of HBV was significantly 
high among the donors who are divorcee 
(30%). This may be attributed to 
exhibition of risky sexual behaviours that 
put them at risk of infection. The age 
group 20 – 29 years, which is the group 
with highest infection rate (by RDT) in this 
study, is the sexually active and mostly 
independent adult group which 
incidentally constitutes the work force of 
the population. Appropriate agencies of 
the Federal Government of Nigeria and 
Non-governmental Organizations (NGO) 
need to redress by re-launching infection 
control programmes to curtail the spread 
of HBV infections. This should be aimed at 
changing high-risk behaviours, which are 
usually denied, among the youths.  
 
 
Table 7: Infection rate of HBV on social demographic characteristics of donors 
 
 Social demographic characteristics           No examined RDTs ELISA 




Single 99 8 (4.8) 8 (5.0)     
 Married 183 35 (11.1) 5 (1.8)     
 Divorced 7 3 (30.0) 0 (0.0)     
 Undisclosed 26 3 (5.3) 1 (1.9)     
 χ2  11.734 4.476     
 p value  0.008 0.214     
Occupation 
Civil Servant 130 20 (8.2) 7 (3.1)      
Business 78 14 (10.3) 2 (1.6)      
Student 27 4 (8.5) 1 (2.3)      
Farmer 36 8 (17.0) 3 (7.3)      
Others 44 3 (3.9) 1 (1.4)      
χ2 6.664 4.431     
p value 0.155 0.351     
Level of Education 
Primary 1 1 (100.0) 0 (0.0)      
Secondary 95 16 2   
Tertiary 196 30 12   
Others 23 2 0   
χ2 10.749 3.465   
p value 0.013 0.325   
Immunization against HBV 
Yes 188 0 (0.0) 11 (2.8)    
No 127 49 (8.9) 3 (2.6)    
χ2 122.578 0.24    
P-value 0.000 8.76    
Exposed to any risk 
Surgery 37 




Blood Transfusion 82 10 (7.1) 0 (0.0)   
Cauterization 45 3 (4.8) 4 (6.6)      
Scarification 37 16 (35.6) 0 (0.0)      
Tattooing 101 5 (2.5) 8 (4.1)      
None 13 1 (2.4) 2 (5.0)      
χ2 69.576 11.156     
p value 0.000 0.048     
Risky Sexual Behavior       
Unprotected sex      41 5 (7.9) 1 (1.7)     
Multiple sexual partners      12 2 (15.4) 1 (9.1)     
Anal sex      16 4 (14.8) 1 (4.3)     
Sexually transmitted diseases      19 4 (12.9) 1 (3.7)     
None      227 34 (8.2) 10 (2.6)     
X2  2.793 2.212     
p value  0.593 0.697     
 
  




 In this study, PCR test achieved 
100% sensitivity, and this extremely high 
sensitivity score was not at the expense of 
specificity, which also had a perfect 
performance. The sensitivity of a test is 
the probability that the test will produce a 
true positive result when used in an 
infected population while specificity is the 
probability that a test will produce a true 
negative result when used in a non-
infected population. Based on the 
predictive values, RDTs test achieved 
100% Positive Predictive Value (PPV), 
while Negative Predictive Value (PPV) 
dropped to 81%. PPV refer to the 
probability that a person is infected with 
HBV when a positive test result is 
observed while NPV is the probability that 
a person is not infected when the test 
result is negative. Generally, in this study, 
ELISA test failed to diagnose NPV of PCR 
negative samples.    
 The best detection method that will 
be suitable in screening blood donors for 
the purpose of eradicating HBV 
transfusion infections was statistically 
calculated using kappa (as shown in 
Tables 4, 5 and 6). Kappa is a measure of 
agreement that tells the extent to which 
two methods or raters will agree with each 
other beyond what might be expected by 
chance alone (Cohen, 1960). Landis and 
Koch (1977) went further in interpreting 
the results of kappa values from 0-1 as 
follows; poor agreement = 0.20 or less, 
fair = 0.20 to 0.40, moderate = 0.40 to 
0.60, good = 0.60 to 0.80 and perfect = 
0.80 to 1.00. The kappa results reported 
in this study indicated a significant fair 
agreement, showing that both RDTs and 
ELISA, and ELISA and PCR methods will 
agree on 304/550 (k=0.304). Also RDTs 
and PCR agree on 550/550 (k=1.000), 
indicating a perfect agreement between 
the two test methods as reported in Table 
6.  
 Similarly, Kappa can be related to 
diagnostic likelihood ratios which are not 
yet commonly reported in peer-reviewed 
literature, but they can be a valuable tool 
for comparing the accuracy of several 
tests to the gold standard. The positive 
diagnostic likelihood ratio (PDLR) 
represents the odds ratio that a positive 
test result will be observed in an infected 
population compared to the odds that the 
same result will be observed among a 
non-infected population. The negative 
diagnostic likelihood ratio (NDLR) which 
represents the odds ratio that a negative 
test result will be observed in non-infected 
population compared to the odds that the 
same result will be observed among an 
infected population.    
 Although there are false negative 
samples observed in this study, the false 
positive rate was minimal. Providing a 
safe blood for the recipients still remains a 
major priority, especially in identifying 
donors at risk of spreading transmissible 
transfusion infections (TTIs) due to 
window period. New techniques of testing 
for HBV will result to zero risk and 
unnecessary deferral of donors with the 
introduction of nucleic acid amplification 
techniques (NAAT), in combination with 
other methods despite its cost. 
 Conclusively, this study recorded a 
higher prevalence rate of hepatitis B 
infection among blood donors in the 
Federal Capital Territory, Abuja, Nigeria. 
No voluntary donor was predisposed to 
hepatitis B infection with a higher 
significant difference at p = 0.008. In 
comparing the sensitivity of HBV detection 
methods namely, RTDs, ELISA and PCR, a 
fair agreement was observed between 
RDTs and ELISA and also between ELISA 
and PCR. A perfect agreement was 
observed between RDT and PCR.  
 It is recommended that upgrade of 
blood bank centres with modern advanced 
technology such as NAAT, in combination 
with other methods, should be employed. 
Encouraging 100% voluntary blood 
donation will reduce TTIs. Compulsory 
universal vaccination against HBV should 
be introduced in Nigeria (especially 
vaccination of neonates at birth in case of 
positive mothers) and the appropriate 
agencies of the Federal Government of 
Nigeria in conjunction with Non-
Governmental Organizations (NGO)  need 
to redress by re-launching infection 
control programmes to curtail the spread 
of HBV infections, with inclusion of HBV 




testing and treatment in the list of 
laboratory tests covered by the National 
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